Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocardial Inflammation in HFpEF
NCT07634640Phase 1Recruiting
- Sponsor
- University of Florida
- Start
- Nov 2023
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ferumoxytol in heart failure with preserved ejection fraction (HFpEF), sponsored by University of Florida. Primary endpoint: Detection of inflammation at 72 hours. Started Nov 2023; status: recruiting.
02
Drugs
ferumoxytol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT07634640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634640.